Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Methylphenidate and atomoxetine enhance prefrontal function through α2-adrenergic and dopamine D1 receptors.

  • Authors : Gamo NJ; Yale University School of Medicine, New Haven, CT, USA.; Wang M

Subjects: Disease Models, Animal*; Adrenergic Uptake Inhibitors/Adrenergic Uptake Inhibitors/Adrenergic Uptake Inhibitors/*therapeutic use ; Central Nervous System Stimulants/Central Nervous System Stimulants/Central Nervous System Stimulants/*therapeutic use

  • Source: Journal of the American Academy of Child and Adolescent Psychiatry [J Am Acad Child Adolesc Psychiatry] 2010 Oct; Vol. 49 (10), pp. 1011-23. Date of Publisher: Elsevier Country of Publication: United States NLM ID: 8704565 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Second opinions improve ADHD prescribing in a medicaid-insured community population.

  • Authors : Thompson JN; Dr. Thompson, Mr. Kwan, and Mr. Lee are with the Washington State Department of Social and Health Services; and Drs. Varley, McClellan, Hilt, Trupin, and Lee are with the University of Washington. Electronic address: .

Subjects: Medicaid*/Medicaid*/Medicaid*/economics ; Referral and Consultation*/Referral and Consultation*/Referral and Consultation*/economics; Adrenergic Uptake Inhibitors/Adrenergic Uptake Inhibitors/Adrenergic Uptake Inhibitors/*administration & dosage

  • Source: Journal of the American Academy of Child and Adolescent Psychiatry [J Am Acad Child Adolesc Psychiatry] 2009 Jul; Vol. 48 (7), pp. 740-748.Publisher: Elsevier Country of Publication: United States NLM ID: 8704565 Publication Model: Print Cited Medium: Internet

Record details

×
Academic Journal

Clinical responses to atomoxetine in attention-deficit/hyperactivity disorder: the Integrated Data Exploratory Analysis (IDEA) study.

  • Authors : Newcorn JH; Dr. Newcorn is with the Department of Psychiatry, Mount Sinai School of Medicine; Dr. Weiss is with the Division of Child Psychiatry, University of British Columbia. Dr. Sutton is with i3 Research

Subjects: Adrenergic Uptake Inhibitors/Adrenergic Uptake Inhibitors/Adrenergic Uptake Inhibitors/*therapeutic use ; Attention Deficit Disorder with Hyperactivity/Attention Deficit Disorder with Hyperactivity/Attention Deficit Disorder with Hyperactivity/*drug therapy ; Propylamines/Propylamines/Propylamines/*therapeutic use

  • Source: Journal of the American Academy of Child and Adolescent Psychiatry [J Am Acad Child Adolesc Psychiatry] 2009 May; Vol. 48 (5), pp. 511-518.Publisher: Elsevier Country of Publication: United States NLM ID: 8704565 Publication Model: Print Cited Medium: Internet

Record details

×
Academic Journal

Effect of two different methods of initiating atomoxetine on the adverse event profile of atomoxetine.

  • Authors : Greenhill LL; Dr. Greenhill is with The New York State Psychiatric Institute/Columbia University, New York; Dr. Newcorn is with Mount Sinai School of Medicine, New York

Subjects: Adrenergic Uptake Inhibitors/Adrenergic Uptake Inhibitors/Adrenergic Uptake Inhibitors/*adverse effects ; Attention Deficit Disorder with Hyperactivity/Attention Deficit Disorder with Hyperactivity/Attention Deficit Disorder with Hyperactivity/*drug therapy ; Propylamines/Propylamines/Propylamines/*adverse effects

  • Source: Journal of the American Academy of Child and Adolescent Psychiatry [J Am Acad Child Adolesc Psychiatry] 2007 May; Vol. 46 (5), pp. 566-572.Publisher: Elsevier Country of Publication: United States NLM ID: 8704565 Publication Model: Print Cited Medium: Print

Record details

×
Academic Journal

CYP2D6 and clinical response to atomoxetine in children and adolescents with ADHD.

Subjects: Adrenergic Uptake Inhibitors/Adrenergic Uptake Inhibitors/Adrenergic Uptake Inhibitors/*pharmacokinetics ; Adrenergic Uptake Inhibitors/Adrenergic Uptake Inhibitors/Adrenergic Uptake Inhibitors/*therapeutic use ; Attention Deficit Disorder with Hyperactivity/Attention Deficit Disorder with Hyperactivity/Attention Deficit Disorder with Hyperactivity/*drug therapy

  • Source: Journal of the American Academy of Child and Adolescent Psychiatry [J Am Acad Child Adolesc Psychiatry] 2007 Feb; Vol. 46 (2), pp. 242-51.Publisher: Elsevier Country of Publication: United States NLM ID: 8704565 Publication Model: Print Cited Medium: Print

Record details

×
Report

Atomoxetine and tics in ADHD.

Subjects: Attention Deficit Disorder with Hyperactivity/Attention Deficit Disorder with Hyperactivity/Attention Deficit Disorder with Hyperactivity/*drug therapy ; Propylamines/Propylamines/Propylamines/*adverse effects ; Tics/Tics/Tics/*chemically induced

  • Source: Journal of the American Academy of Child and Adolescent Psychiatry [J Am Acad Child Adolesc Psychiatry] 2004 Sep; Vol. 43 (9), pp. 1068-9.Publisher: Elsevier Country of Publication: United States NLM ID: 8704565 Publication Model: Print Cited Medium: Print

Record details

×
  • 1-8 of  8 results for ""Dose-Response Relationship, Drug""